Dokument
Engineering humanisation of antibodies with good developability profiles
2011-06-06 08:42Lonza: This poster shows how the Lonza Biologics AggreSolve platform has been expanded and successfully applied to engineer humanized antibodies with good developability profiles; such antibodies have good stability, productivity and retain activity of therapeutic levels, eliminating the need for further, potentially destabilizing, affinity maturation.

Lägg till kommentarKommentaren sparades
Innan den publiceras måste den godkännas av Attana AB.